Stockscreener 앱 받기
4.69
3.30%
-0.16
전일 마감가:
$4.85
열려 있는:
$4.848
하루 거래량:
24,023
Relative Volume:
1.06
시가총액:
$8.67M
수익:
-
순이익/손실:
$-7.30M
주가수익비율:
-0.5756
EPS:
-8.148
순현금흐름:
$-8.01M
1주 성능:
+6.11%
1개월 성능:
-7.13%
6개월 성능:
-5.06%
1년 성능:
+38.35%
1일 변동 폭
$4.34
$4.928
1주일 범위
$4.15
$5.00
52주 변동 폭
$2.96
$11.96
Endra Life Sciences Inc Stock (NDRA) Company Profile
명칭
Endra Life Sciences Inc
전화
734-335-0468
주소
3600 GREEN COURT, ANN ARBOR, MI
Compare NDRA vs TMO, DHR, IDXX, A, WAT
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
NDRA
Endra Life Sciences Inc
|
4.69 | 8.97M | 0 | -7.30M | -8.01M | -8.148 |
TMO
Thermo Fisher Scientific Inc
|
472.63 | 176.04B | 45.20B | 6.87B | 6.75B | 18.19 |
DHR
Danaher Corp
|
181.35 | 128.18B | 24.78B | 3.68B | 5.29B | 5.1743 |
IDXX
Idexx Laboratories Inc
|
573.00 | 44.96B | 4.45B | 1.10B | 1.06B | 13.59 |
A
Agilent Technologies Inc
|
128.34 | 36.88B | 7.23B | 1.41B | 1.09B | 4.979 |
WAT
Waters Corp
|
360.54 | 35.13B | 3.77B | 449.25M | 240.68M | 7.8556 |
Endra Life Sciences Inc 주식(NDRA)의 최신 뉴스
NDRA Technical Analysis & Stock Price Forecast - Intellectia AI
ENDRA Life Sciences (NDRA) Jumps 11% as Momentum Builds Toward Key ResistanceSystematic Flow - newsline.com
NDRA | ENDRA Life Sciences Inc. Insider Trading - Quiver Quantitative
ENDRA Life Sciences (NASDAQ: NDRA) Emerging Diagnostic - openPR.com
NDRA Q1 2026 Earnings: Wider-than-Expected Loss Amid No RevenueLong-Term Guidance - newsline.com
NDRA Q1 2026 Earnings: EPS Misses Estimates Amid Continued Development Stage OperationsEarnings Volatility Report - newsline.com
NDRA News | ENDRA LIFE SCIENCES INC (NASDAQ:NDRA) - ChartMill
NDRA Maintained by Ascendiant Capital -- Price Target Lowered to $25 - GuruFocus
Dell Technologies To Gain Nearly 79%? Here Are 10 Analyst Calls Investors Should Know - Benzinga
ENDRA Life Sciences (NDRA) Holds Steady Near Support as Micro-Cap Biotech Awaits CatalystsDealer Positioning - The Legal Advocate
ENDRA Life Sciences Withdraws Filing for Securities Offering - Moomoo
ENDRA Life Sciences Inc. Announces Private Placement Securities Purchase Agreement and Issuance of Warrants – May 2026 - Minichart
ENDRA Life Sciences Announces Strategic Private Placement Financing - TipRanks
ENDRA Life Sciences Raises $3.8 Million in Private Placement; Sets Cash Safeguards in Side Letter - TradingView
ENDRA Life Sciences (NASDAQ: NDRA) raises $3.8M to bolster equity for Nasdaq - Stock Titan
Stocks to Watch: NDRA, SBFM, GOVX, HIVE, ANY Trading Actively NOW! - marketscreener.com
ENDRA Life Sciences (NASDAQ: NDRA) Beats Q1 Expectations, TAEUS - openPR.com
ENDRA Life Sciences Inc. announced that it expects to receive $3.800003 million in funding - marketscreener.com
[RW] ENDRA Life Sciences Inc. SEC Filing - Stock Titan
ENDRA Life Sciences NDRA Shows Modest Gains Testing Resistance at 573The Legal Advocate - The Legal Advocate
NDRA Q1 2026 Earnings: Wider-Than-Expected Loss as Pre-Revenue Stage ContinuesEarnings Manipulation Risk - Newser
ENDRA Life Sciences Q1 2026 Earnings: Wider-Than-Expected Loss as Pre-Revenue Biotech Continues DevelopmentUpward Estimate Revision - Newser
ENDRA Life Sciences (NDRA) Shows Modest Gains, Testing Resistance at $5.73Option Breadth - newsline.com
ENDRA Life Sciences Q1 2026 Earnings: EPS Misses Estimates as Development ContinuesQuarterly Financial Update - The Legal Advocate
ENDRA Life Sciences Inc.Common Stock (NQ: NDRA - The Chronicle-Journal
NDRA Stock Price, Quote & Chart | ENDRA LIFE SCIENCES INC (NASDAQ:NDRA) - ChartMill
Endra Life Sciences reports Q1 EPS ($1.09) vs. ($1.86) last year - TipRanks
NDRA Strengthens Clinical Foundation for TAEUS Liver Technology - GuruFocus
ENDRA Life Sciences Reports First Quarter 2026 Financial Results and Provides Business Update - Business Wire
ENDRA Life Sciences Inc reports results for the quarter ended March 31Earnings Summary - TradingView
ENDRA Life Sciences (NASDAQ: NDRA) faces Nasdaq equity notice after Q1 loss - Stock Titan
ENDRA Life Sciences Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 - marketscreener.com
ENDRA Life (NDRA) Q4 2025 Results Miss Estimates — EPS $-3.26 vs $-1.25Expert Stock Picks - Newser
NDRA Q1'26 Earnings: EPS estimate is (1.23) USD - TradingView
Endra Life Sciences (NDRA) Achieves Promising Results with TAEUS Liver - GuruFocus
Endra Life Sciences reports multi-site validation of TAEUS Liver device - TipRanks
ENDRA Life Sciences Reports Multi-Site Validation of TAEUS® Liver Device Demonstrating MRI-like Accu - PharmiWeb.com
ENDRA Life Sciences Reports Multi-Site Validation of TAEUS® Liver Device Demonstrating MRI-like Accuracy and Reproducibility - BioSpace
ENDRA reports multi-site validation results for liver imaging device - Investing.com UK
ENDRA reports multi-site validation results for liver imaging device By Investing.com - Investing.com Australia
Liver Device Demonstrating MRI-like Accuracy and Reproducibility - Business Wire
TradingKey - TradingKey
ENDRA Life Sciences (NASDAQ: NDRA) Heats Up as Diagnostic Play - openPR.com
Is ENDRA Life (NDRA) stock suitable for your portfolio? (Nudges Down) 2026-04-27Senior Analyst Forecasts - Newser
Endra Life Sciences Inc (NDRA) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.56%
0.44%
자본화:
|
볼륨(24시간):